Nanexa invites to Capital Markets Day on May 7
Nanexa AB invites investors, analysts and other stakeholders to a Capital Markets Day on Tuesday, May 7, at 1:00-3:00 pm at the Royal Swedish Academy of Engineering Sciences (IVA) in Stockholm.
At the event, Nanexa's Chairman Göran Ando, CEO David Westberg and members of the management team will provide an in-depth description of the business, focusing on the following areas:
- Status and ongoing development within Nanexa's own NEX-22 project
- Nanexa's collaboration with Novo Nordisk and other prioritized partner projects
- Status and ongoing development of Nanexa's PharmaShell system, and experience from pre-clinical and clinical studies
- The larger perspective of the GLP-1 market in type 2 diabetes and obesity
- Business development – experiences and opportunities ahead
- Focus 2024-2025 – Nanexa's plan to ensure continued growth and success
The presentations will be held in Swedish and participants will have the opportunity to ask questions directly to the speakers. For those who cannot attend, the event will be recorded and made available on the Nanexa website afterwards.
Date: Tuesday May 7, 2024
Time: 1:00-3:00 pm. Coffee will be served in connection
Place: Royal Swedish Academy of Engineering Sciences (IVA), Grev Turegatan 16, Stockholm.
Registration: You are welcome to register by e-mail to maria.medeen@nanexa.se by May 3.
